Hsu C - Search Results

1

Spectrum of cancer patients receiving renal biopsy.

Chang FC, Chen TW, Huang TT, Lin WC, Liu JS, Chiang WC, Chen YM, Hsu C, Yeh KH, Chu TS. Chang FC, et al. Among authors: hsu c. J Formos Med Assoc. 2022 Jan;121(1 Pt 1):152-161. doi: 10.1016/j.jfma.2021.02.009. Epub 2021 Feb 25. J Formos Med Assoc. 2022. PMID: 33640191 Free article.

2

MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer.

Hsu C, Yeh KH, Hong RL, Yang CH, Lin MT, Chen YC, Cheng AL. Hsu C, et al. J Formos Med Assoc. 1997 Mar;96(3):185-8. J Formos Med Assoc. 1997. PMID: 9080756

3

Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.

Cheng AL, Yeh KH, Lin JT, Hsu C, Liu MY. Cheng AL, et al. Among authors: hsu c. Anticancer Res. 1998 Mar-Apr;18(2B):1267-72. Anticancer Res. 1998. PMID: 9615799 Clinical Trial.

4

Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer.

Yang CH, Tsai CM, Wang LS, Lee YC, Chang CJ, Lui LT, Yen SH, Hsu C, Cheng AL, Liu MY, Chiang SC, Chen YM, Luh KT, Huang MH, Yang PC, Perng RP. Yang CH, et al. Among authors: hsu c. Br J Cancer. 2002 Jan 21;86(2):190-5. doi: 10.1038/sj.bjc.6600044. Br J Cancer. 2002. PMID: 11870504 Free PMC article. Clinical Trial.

5

A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.

Hsu CH, Cheng AL, Hsu C, Yang CH, Lu YS, Lin CC, Bu CF, Yeh KH. Hsu CH, et al. Among authors: hsu c. Anticancer Res. 2002 Nov-Dec;22(6B):3621-7. Anticancer Res. 2002. PMID: 12552966 Clinical Trial.

6

Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.

Lu YS, Hsu C, Li CC, Kuo SH, Yeh KH, Yang CH, Hsu CH, Wu CY, Cheng AL. Lu YS, et al. Among authors: hsu c, hsu ch. Hepatogastroenterology. 2004 May-Jun;51(57):815-9. Hepatogastroenterology. 2004. PMID: 15143923 Clinical Trial.

7

Recent advances in non-surgical treatment for advanced hepatocellular carcinoma.

Hsu C, Cheng JC, Cheng AL. Hsu C, et al. J Formos Med Assoc. 2004 Jul;103(7):483-95. J Formos Med Assoc. 2004. PMID: 15318270 Review.

8

Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer.

Yeh KH, Lu YS, Hsu CH, Lin JF, Hsu C, Kuo SH, Li SJ, Cheng AL. Yeh KH, et al. Among authors: hsu c, hsu ch. Oncology. 2005;69(1):88-95. doi: 10.1159/000087304. Epub 2005 Aug 2. Oncology. 2005. PMID: 16088236 Clinical Trial.

9

Gefitinib treatment for non-small cell lung cancer -- a study including patients with poor performance status.

Su WP, Yang CH, Yu CJ, Shih JY, Hsu C, Yang PC. Su WP, et al. Among authors: hsu c. J Formos Med Assoc. 2005 Aug;104(8):557-62. J Formos Med Assoc. 2005. PMID: 16193176

10

A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.

Lin CC, Cheng AL, Hsu CH, Lu YS, Hsu C, Yeh KH, Wu CY, Huang CS, Yang CH. Lin CC, et al. Among authors: hsu c, hsu ch. Anticancer Res. 2007 Jan-Feb;27(1B):641-5. Anticancer Res. 2007. PMID: 17348454 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,535 results

Search Page

Filters